Peter le, MD
Gastroenterology · Castle Rock, CONPI 1942460209
Payments from drug & device makers
Across 660 payments — averaging $209.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Phathom Pharmaceuticals, Inc.$54K
- Takeda Pharmaceuticals U.S.A., Inc.$35K
- AbbVie$32K
- Ardelyx, Inc.$9K
- Ironwood Pharmaceuticals, Inc$2K
- Johnson & Johnson$767
- plus $5K from 26 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 78 | $54,182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 101 | $34,831 |
| AbbVie(2 entities) | 172 | $32,313 |
| Ardelyx, Inc. | 25 | $8,975 |
| Ironwood Pharmaceuticals, Inc | 7 | $2,453 |
| Johnson & Johnson(3 entities) | 36 | $767 |
| Bristol Myers Squibb | 46 | $732 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 39 | $729 |
| Pfizer | 39 | $589 |
| Lilly USA, LLC | 15 | $401 |
| Sanofi | 18 | $347 |
| Regeneron Healthcare Solutions, Inc. | 12 | $291 |
| Gilead | 14 | $288 |
| QOL Medical, LLC | 10 | $216 |
| Intercept Pharmaceuticals, Inc. | 7 | $117 |
| Organon | 6 | $100 |
| Ipsen Biopharmaceuticals, Inc | 4 | $94 |
| Ferring Pharmaceuticals Inc. | 4 | $78 |
| Merck | 4 | $72 |
| Nestle Healthcare Nutrition Inc. | 4 | $66 |
| Redhill Biopharma Inc. | 4 | $59 |
| UCB, Inc. | 2 | $53 |
| Madrigal Pharmaceuticals | 2 | $52 |
| Micro-tech Endoscopy USA, Inc. | 1 | $51 |
| Laborie Medical Technologies Corp. | 1 | $42 |
| Shire North American Group Inc | 2 | $39 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Amgen | 1 | $22 |
| Braintree Laboratories, Inc. | 1 | $20 |
| Alfasigma USA, Inc. | 1 | $18 |
| Albireo Pharma, Inc. | 1 | $15 |
| Novo Nordisk | 1 | $14 |
How this compares
$138,055 in reported general payments places this provider in the 90th percentile of 304 gastroenterology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Castle Rock
- Christopher HaydekCastle Rock$112K
- Lisa MathewCastle Rock$10K
- Bhaktasharan PatelColorado Springs$22M
- Marcelo KugelmasEnglewood$2.7M
- Douglas AdlerColorado Springs$1.2M
- Masi KhajaGrand Junction$1.2M
- Peter McNallyFt Carson$1.1M
- Mark GerichAurora$1M
- Raj ShahAurora$764K
- Rajesh JainLakewood$708K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.